Neuralink implants the first human brain chip
Image credit: Neuralink
Elon Musk’s brain-chip startup Neuralink achieved a significant milestone on Sunday, January 28, 2024, by implanting its first human patient with a brain-computer interface. Musk said on Monday the patient is recovering well and initial results are showing neuron spike detection.
In a significant advancement in brain-computer interface (BCI) technology, Neuralink, a company founded by Elon Musk, has successfully implanted its first human patient with a brain-chip. The implantation, which took place on January 28, 2024, has shown promising initial results in neuron spike detection, as announced by Musk.
The first product from Neuralink, named ‘Telepathy,’ enables users to control phones or computers, and subsequently any connected device, merely through thought. This groundbreaking technology is particularly aimed at helping individuals who have lost the use of their limbs. Musk illustrated the potential impact of this technology by referencing the late Stephen Hawking, suggesting that similar individuals could communicate faster than a speed typist or auctioneer.
Neuralink uses a robot to surgically place the BCI in a brain region controlling movement intention. The company’s stated mission is to create a generalized brain interface to restore autonomy to individuals with unmet medical needs and to unlock human potential. The BCI, inserted into the brain by Neuralink’s surgical robot, is cosmetically invisible and designed to wirelessly transmit brain signals to an app that decodes movement intention.
In May 2023, the U.S. Food and Drug Administration (FDA) granted Neuralink clearance to conduct its first human trial. This approval followed an earlier rejection in 2022 due to major safety concerns.
In September 2023, Neuralink announced a significant step forward when it received the green light to start recruiting participants for its first human clinical trial. This trial, named the PRIME Study (Precise Robotically Implanted Brain-Computer Interface), represents a pivotal moment in the field of medical device research. The study’s primary objective is to evaluate the safety and initial functionality of Neuralink’s fully implantable, wireless BCI technology.
The study focuses on their implant, known as N1, and the surgical robot, R1. The N1 implant is designed with ultra-fine and flexible threads that are surgically placed into a specific brain region that governs movement intention using the R1 Robot. Once implanted, the N1 device is cosmetically invisible and functions to record and wirelessly transmit brain signals to an application that decodes the user’s movement intention.
References:
1 Neuralink.com – Accessed January 30, 2024
2 Neuralink’s First-in-Human Clinical Trial is Open for Recruitment – Neuralink – September 19, 2023
The Watchers team and our contributors bring the latest on extreme weather, earthquakes, volcanic eruptions, space weather, and all things science. We're all about making sense of the natural world and keeping you informed on what’s happening. Got a tip or a question? Hit us up using the form at newstips!
Published in the last 24 hours
- The storms drenching California this week are fed by a river in the sky, a band of water vapor that can carry up to 15 times the flow of the Mississippi River, and this winter’s near-record El Niño could keep aiming more of them at the West Coast
- Malawi continues Bris AI weather forecasting tests ahead of operational integration Epicenter
- Right about now, Voyager 1 is crossing a line no human-made object has ever reached, a full light-day from Earth, which means a message NASA sends tonight won't arrive until tomorrow night, and the spacecraft's answer won't make it home until the night after that
- G1 geomagnetic storm watch remains in effect as NOAA forecasts Kp 4.67 late on November 17 and early on November 18


